UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab

British journal of cancer, 2013-06, Vol.108 (12), p.2549-2556

2013

Link zum Volltext

Verfügbarkeit prüfen

Canakinumab for the treatment of TNF-receptor associated periodic syndrome

Expert review of clinical immunology, 2017-06, Vol.13 (6), p.513-523

2017

Link zum Volltext

Verfügbarkeit prüfen

Unusual onset of a case of chronic recurrent multifocal osteomyelitis

Pediatric rheumatology online journal, 2015-12, Vol.13 (1), p.60-60, Article 60

2015

Link zum Volltext

Verfügbarkeit prüfen

Early changes in plasma levels of mutant KRAS DNA as a sensitive marker of response to chemotherapy in pancreatic cancer

Annals of oncology, 2017-10, Vol.28, p.vi47-vi47

2017

Link zum Volltext

Verfügbarkeit prüfen

A pneumatic dilation strategy in achalasia: prospective outcome and effects on oesophageal motor function in the long term

Alimentary pharmacology & therapeutics, 2010-03, Vol.31 (6), p.658-665

2010

Link zum Volltext

Verfügbarkeit prüfen

A retrospective analysis of patients (pts) with non-small-cell lung cancer (NSCLC) with uncommon or complex epidermal growth factor receptor (EGFR) mutations treated with tyrosine kinase inhibitors (EGFR-TKIs): clinical features and outcome

Annals of oncology, 2017-10, Vol.28, p.vi56-vi56

2017

Link zum Volltext

Verfügbarkeit prüfen

2362 Second-line treatment after disease progression following first-line chemotherapy with modified FOLFIRINOX in advanced pancreatic cancer patients

European journal of cancer (1990), 2015-09, Vol.51, p.S456-S457

2015

Link zum Volltext

Verfügbarkeit prüfen

PD-022FOLFOXIRI as primary treatment for locally advanced unresectable pancreatic cancer (LAPC): a prospective study

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii109-ii110

2016

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms

European journal of surgical oncology, 2013-04, Vol.39 (4), p.396-403

2013

Link zum Volltext

Verfügbarkeit prüfen

Not only chemotherapy in the second-line treatment of metastatic gastric cancer

Annals of oncology, 2014-02, Vol.25 (2), p.544-545

2014

Link zum Volltext

Verfügbarkeit prüfen

2372 Is there a role for palliative gastrectomy in asymptomatic metastatic gastric cancer?

European journal of cancer (1990), 2015-09, Vol.51, p.S460-S461

2015

Link zum Volltext

Verfügbarkeit prüfen

P985 CONCOMITANT VERSUS SEQUENTIAL TREATMENT WITH TACE AND SORAFENIB IN HEPATOCELLULAR CARCINOMA PATIENTS

Journal of hepatology, 2014-04, Vol.60 (1), p.S403-S403

2014

Link zum Volltext

Verfügbarkeit prüfen

Traditional vs wireless intragastric pH monitoring: are the two techniques comparable?

Neurogastroenterology and motility, 2012-10, Vol.24 (10), p.951-e464

2012

Link zum Volltext

Verfügbarkeit prüfen

Circulating micrornas as dynamic biomarkers of disease progression during folfirinox therapy in unresectable pancreatic ductal adenocarcinoma (pdac)

HPB (Oxford, England), 2016-04, Vol.18, p.e43-e44

2016

Link zum Volltext

Verfügbarkeit prüfen

Concomitant versus sequential treatment with TACE and sorafenib in HCC patients

Digestive and liver disease, 2014-02, Vol.46, p.e37-e37

2014

Link zum Volltext

Verfügbarkeit prüfen

Identification of responders to sorafenib in hepatocellular carcinoma: Is tumour volume measurement the way forward?

Digestive and liver disease, 2013-10, Vol.45, p.e370-e370

2013

Link zum Volltext

Verfügbarkeit prüfen

Role of Symptoms, Trend of Liver Tests, and Endotherapy in Management of Post-Cholecystectomy Biliary Leak

Digestive diseases and sciences, 2011-05, Vol.56 (5), p.1565-1571

2011

Link zum Volltext

Verfügbarkeit prüfen

P.23 PNEUMATIC DILATION IN ACHALASIA: PROSPECTIVE OUTCOME AND EFFECTS ON OESOPHAGEAL MOTOR FUNCTION IN THE LONG-TERM

Digestive and liver disease, 2010, Vol.42, p.S111-S111

2010

Link zum Volltext

Verfügbarkeit prüfen

New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?

OncoTargets and therapy, 2016-01, Vol.9, p.6065-6074

2016

Link zum Volltext

Verfügbarkeit prüfen

P-180 Second-line treatment after disease progression following first-line chemotherapy with modified FOLFIRINOX in advanced pancreatic cancer patients: a single institution retrospective cohort study

Annals of oncology, 2015-06, Vol.26, p.iv52

2015

Link zum Volltext

Verfügbarkeit prüfen

PA.97 MANAGEMENT AND LONG-TERM OUTCOME OF PATIENTS WITH POST-CHOLECYSTECTOMY BILIARY LEAK

Digestive and liver disease, 2008, Vol.40, p.S110-S110

2008

Link zum Volltext

Verfügbarkeit prüfen

OC1.10.3 COMPUTER SIMULATOR AND EXPERT COLONOSCOPISTS. IS INFORMATION USEFUL?

Digestive and liver disease, 2008, Vol.40, p.S30-S30

2008

Link zum Volltext

Verfügbarkeit prüfen

Palliative gastrectomy in asymptomatic metastatic esophagogastric cancer (EGC): does it make sense?

Annals of oncology, 2015-10, Vol.26, p.vi98

2015

Link zum Volltext

Verfügbarkeit prüfen

Single-centre experience with third-line chemotherapy with irinotecan plus 5-fluorouracil and leucovorin (FOLFIRI) in metastatic gastric cancer patients

Annals of oncology, 2015-10, Vol.26, p.vi99

2015

Link zum Volltext

Verfügbarkeit prüfen

Tolerability of FOLFOXIRI regimen after surgical resection for pancreatic cancer

Annals of oncology, 2015-10, Vol.26, p.vi105

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Humans
(11)
Female
(9)
Male
(8)
Gastroenterology And Hepatology
(7)
Adult
(6)
Middle Aged
(6)
Oncology
(6)
Aged
(5)
Retrospective Studies
(4)
Aged, 80 And Over
(3)
Biological And Medical Sciences
(3)
Child
(3)
Gastroenterology & Hepatology
(3)
Hematology, Oncology And Palliative Medicine
(3)
Italy
(3)
Medical Sciences
(3)
Camptothecin - Analogs & Derivatives
(2)
Cancer Therapies
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab

Canakinumab for the treatment of TNF-receptor associated periodic syndrome

Unusual onset of a case of chronic recurrent multifocal osteomyelitis

Early changes in plasma levels of mutant KRAS DNA as a sensitive marker of response to chemotherapy in pancreatic cancer

A pneumatic dilation strategy in achalasia: prospective outcome and effects on oesophageal motor function in the long term

A retrospective analysis of patients (pts) with non-small-cell lung cancer (NSCLC) with uncommon or complex epidermal growth factor receptor (EGFR) mutations treated with tyrosine kinase inhibitors (EGFR-TKIs): clinical features and outcome

2362 Second-line treatment after disease progression following first-line chemotherapy with modified FOLFIRINOX in advanced pancreatic cancer patients

PD-022FOLFOXIRI as primary treatment for locally advanced unresectable pancreatic cancer (LAPC): a prospective study

Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms

Not only chemotherapy in the second-line treatment of metastatic gastric cancer

2372 Is there a role for palliative gastrectomy in asymptomatic metastatic gastric cancer?

P985 CONCOMITANT VERSUS SEQUENTIAL TREATMENT WITH TACE AND SORAFENIB IN HEPATOCELLULAR CARCINOMA PATIENTS

Traditional vs wireless intragastric pH monitoring: are the two techniques comparable?

Circulating micrornas as dynamic biomarkers of disease progression during folfirinox therapy in unresectable pancreatic ductal adenocarcinoma (pdac)

Concomitant versus sequential treatment with TACE and sorafenib in HCC patients

Identification of responders to sorafenib in hepatocellular carcinoma: Is tumour volume measurement the way forward?

Role of Symptoms, Trend of Liver Tests, and Endotherapy in Management of Post-Cholecystectomy Biliary Leak

P.23 PNEUMATIC DILATION IN ACHALASIA: PROSPECTIVE OUTCOME AND EFFECTS ON OESOPHAGEAL MOTOR FUNCTION IN THE LONG-TERM

New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?

P-180 Second-line treatment after disease progression following first-line chemotherapy with modified FOLFIRINOX in advanced pancreatic cancer patients: a single institution retrospective cohort study

PA.97 MANAGEMENT AND LONG-TERM OUTCOME OF PATIENTS WITH POST-CHOLECYSTECTOMY BILIARY LEAK

OC1.10.3 COMPUTER SIMULATOR AND EXPERT COLONOSCOPISTS. IS INFORMATION USEFUL?

Palliative gastrectomy in asymptomatic metastatic esophagogastric cancer (EGC): does it make sense?

Single-centre experience with third-line chemotherapy with irinotecan plus 5-fluorouracil and leucovorin (FOLFIRI) in metastatic gastric cancer patients

Tolerability of FOLFOXIRI regimen after surgical resection for pancreatic cancer

Suchergebnisse filtern